Mbx Biosciences
Clinical trials sponsored by Mbx Biosciences, explained in plain language.
-
New obesity drug MBX 4291 enters first human safety trial
Disease control Recruiting nowThis early-stage study is testing an experimental drug, MBX 4291, in 124 adults with obesity. The main goal is to check the drug's safety and how the body processes it. Participants will receive either the drug or a placebo as a shot under the skin, and researchers will monitor f…
Phase: PHASE1 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New shot aims to stop dangerous sugar crashes after gastric bypass
Disease control Recruiting nowThis study tests a new drug called MBX 1416 in 10 people who have low blood sugar episodes after weight loss surgery. Participants receive two injections of the drug, a low dose and a high dose, about two weeks apart. The goal is to see if the drug can raise the lowest blood suga…
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC